{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:55:32Z","timestamp":1786550132996,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1038\/ajg.2017.52","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T09:01:43Z","timestamp":1489482103000},"page":"903-909","source":"Crossref","is-referenced-by-count":13,"title":["Polymorphisms of 5-HTT LPR and GN\u03b23 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial"],"prefix":"10.14309","volume":"112","author":[{"given":"Yuri A","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G","family":"Locke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E","family":"Almazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest P","family":"Bouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin W","family":"Howden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K","family":"DiBaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene M","family":"Prather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bincy P","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashem B","family":"El-Serag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moayyedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M","family":"Herrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence A","family":"Szarka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy D","family":"Schleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E","family":"Tilkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R","family":"Zinsmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J","family":"Talley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210210","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00535-015-1076-x","article-title":"Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.","volume":"50","author":"Talley","year":"2015","journal-title":"J Gastroenterol"},{"key":"R2-21-20210210","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nrgastro.2013.14","article-title":"Functional dyspepsiasymptoms, definitions and validity of the Rome III criteria.","volume":"10","author":"Tack","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R3-21-20210210","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","article-title":"Functional gastroduodenal disorders.","volume":"130","author":"Tack","year":"2006","journal-title":"Gastroenterology"},{"key":"R4-21-20210210","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1053\/gast.1996.v110.pm8612991","article-title":"Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia.","volume":"110","author":"Stanghellini","year":"1996","journal-title":"Gastroenterology"},{"key":"R5-21-20210210","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/j.1572-0241.1999.01281.x","article-title":"Predominant symptoms identify different subgroups in functional dyspepsia.","volume":"94","author":"Stanghellini","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R6-21-20210210","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1572-0241.2001.03683.x","article-title":"Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia?","volume":"96","author":"Talley","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R7-21-20210210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/apt.13006","article-title":"Systematic review with meta-analysis: post-infectious functional dyspepsia.","volume":"41","author":"Futagami","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R8-21-20210210","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/jgh.12419","article-title":"Duodenal eosinophilia and early satiety in functional dyspepsia: confirmation of a positive association in an Australian cohort.","volume":"29","author":"Walker","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"R9-21-20210210","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2036.2010.04282.x","article-title":"Implications of eosinophilia in the normal duodenal biopsyan association with allergy and functional dyspepsia.","volume":"31","author":"Walker","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R10-21-20210210","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/ajg.2012.104","article-title":"Functional dyspepsia and gastroparesis: one disease or two?","volume":"107","author":"Lacy","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R11-21-20210210","first-page":"30","article-title":"Antidepressants as analgesics: a review of randomized controlled trials.","volume":"26","author":"Lynch","year":"2001","journal-title":"J Psychiatry Neurosci"},{"key":"R12-21-20210210","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1365-2036.2003.01575.x","article-title":"Systematic review: antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia.","volume":"17","author":"Moayyedi","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-21-20210210","first-page":"660","article-title":"Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials.","volume":"91","author":"Veldhuyzen van Zanten","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"R14-21-20210210","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0002-9270(00)02314-5","article-title":"Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis.","volume":"96","author":"Veldhuyzen van Zanten","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R15-21-20210210","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1572-0241.1998.00160.x","article-title":"Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia.","volume":"93","author":"Mertz","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R16-21-20210210","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/00365529609006404","article-title":"A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin.","volume":"31","author":"Tanum","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"R17-21-20210210","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2003.01469.x","article-title":"Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans.","volume":"17","author":"Tack","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R19-21-20210210","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.RES.85.10.965","article-title":"G protein beta3 subunit 825T allele and enhanced coronary vasoconstriction on alpha(2)-adrenoceptor activation.","volume":"85","author":"Baumgart","year":"1999","journal-title":"Circ Res"},{"key":"R20-21-20210210","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.gastro.2004.01.006","article-title":"G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia.","volume":"126","author":"Holtmann","year":"2004","journal-title":"Gastroenterology"},{"key":"R21-21-20210210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2350-11-13","article-title":"The G-protein beta3 subunit 825 TT genotype is associated with epigastric pain syndrome-like dyspepsia.","volume":"11","author":"Oshima","year":"2010","journal-title":"BMC Med Genet"},{"key":"R23-21-20210210","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000054929","article-title":"Association analysis of a functional G protein beta3 subunit gene polymorphism (C825T) in mood disorders.","volume":"44","author":"Lin","year":"2001","journal-title":"Neuropsychobiology"},{"key":"R24-21-20210210","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1097\/00001756-200006260-00018","article-title":"Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment.","volume":"11","author":"Zill","year":"2000","journal-title":"Neuroreport"},{"key":"R25-21-20210210","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.274.5292.1527","article-title":"Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.","volume":"274","author":"Lesch","year":"1996","journal-title":"Science"},{"key":"R27-21-20210210","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cct.2012.02.002","article-title":"3rd, Herrick LM et al. Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics.","volume":"33","author":"Talley","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"R28-21-20210210","first-page":"40","article-title":"Antimuscarinic and other receptor-blocking properties of antidepressants.","volume":"58","author":"Richelson","year":"1983","journal-title":"Mayo Clin Proc"},{"key":"R29-21-20210210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00213-002-1364-z","article-title":"Escitalopram, the S-()-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.","volume":"167","author":"Sanchez","year":"2003","journal-title":"Psychopharmacology"},{"key":"R30-21-20210210","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5009\/gnl.2014.8.3.271","article-title":"G protein beta3 subunit polymorphism and long-term prognosis of functional dyspepsia.","volume":"8","author":"Chung","year":"2014","journal-title":"Gut Liver"},{"key":"R31-21-20210210","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-2982.2008.01102.x","article-title":"Candidate genotypes associated with functional dyspepsia.","volume":"20","author":"Van Lelyveld","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"R32-21-20210210","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2350-12-88","article-title":"Serotonin transporter gene polymorphism may be associated with functional dyspepsia in a Japanese population.","volume":"12","author":"Toyoshima","year":"2011","journal-title":"BMC Med Genet"},{"key":"R33-21-20210210","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2217\/pgs.15.12","article-title":"Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders.","volume":"16","author":"Martinucci","year":"2015","journal-title":"Pharmacogenomics"},{"key":"R34-21-20210210","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1572-0241.2006.00480.x","article-title":"Hypothesis driven research and molecular mechanisms in functional dyspepsia: the beginning of a beautiful friendship in research and practice?","volume":"101","author":"Holtmann","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R35-21-20210210","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1038\/ajg.2009.319","article-title":"AJG series: molecular biology for clinicians.","volume":"104","author":"Saito","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R36-21-20210210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1017\/S1461145702002936","article-title":"Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions.","volume":"5","author":"Lerer","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"R37-21-20210210","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/0269881110376683","article-title":"Variation in GNB3 predicts response and adverse reactions to antidepressants.","volume":"25","author":"Keers","year":"2011","journal-title":"J Psychopharmacol"},{"key":"R38-21-20210210","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1053\/gast.2002.34780","article-title":"Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome.","volume":"123","author":"Camilleri","year":"2002","journal-title":"Gastroenterology"},{"key":"R39-21-20210210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/nedt.1.1.17.52301","article-title":"Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.","volume":"1","author":"Lotrich","year":"2005","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R40-21-20210210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.mp.4001926","article-title":"Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients.","volume":"12","author":"Serretti","year":"2007","journal-title":"Mol Psychiatry"},{"key":"R41-21-20210210","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2350-12-140","article-title":"Serotonin receptor 3A polymorphism c.-42CT is associated with severe dyspepsia.","volume":"12","author":"Mujakovic","year":"2011","journal-title":"BMC Med Genet"},{"key":"R42-21-20210210","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s11920-015-0594-9","article-title":"Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.","volume":"17","author":"Fabbri","year":"2015","journal-title":"Curr Psychiatry Rep"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000434-201706000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:15:40Z","timestamp":1786547740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201706000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2017.52","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}